DDX3X regulates DNA repair pathway choice at double-strand breaks via RNA-DNA hybrid formation.
It is concluded that DDX3X promotes genome maintenance and cell viability following DSB formation through regulation of BIRDHs and sensitizes tumor cells to cisplatin in vitro and in vivo.